Demyelinating events in early multiple sclerosis have inherent severity and recovery
- 17 February 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 72 (7), 602-608
- https://doi.org/10.1212/01.wnl.0000342458.39625.91
Abstract
It is unclear whether the severity of and recovery from the initial demyelinating event (IDE) are recapitulated in subsequent multiple sclerosis (MS) relapses. We sought to identify the factors associated with relapse severity and recovery and to evaluate whether events have inherent severity or recovery. Patients seen at the UCSF MS Clinic within 1 year of disease onset were identified from a prospective database. Ordinal logistic regression was used to analyze predictors of three-level categorizations of event severity and recovery. We identified 330 patients with MS or clinically isolated syndrome; 152 had a second event and 63 had a third event. Nonwhite and younger patients were at an increased risk of more severe demyelinating events. A severe prior event predicted a substantial increase in the odds of being above any given severity cutoff for a severe subsequent event (for second event severity, odds ratio [OR] = 5.62, 95% confidence interval [CI] [2.39, 13.26], p < 0.0001; for third event severity, OR = 6.74, 95% CI [1.67, 27.18], p = 0.007). Similarly, poor recovery of the IDE predicted poor second event recovery (OR = 5.28, 95% CI [1.95, 14.25], p = 0.001), while fair or poor second event recovery predicted about a 5- or 13-fold increase in the odds of poor third event recovery. A more severe event also predicted a substantial increase in the odds of poor recovery. Patients with severe presentation and poor recovery at disease onset continue on a similar trajectory with subsequent demyelinating events. Whether genetic or other biologic factors are responsible for this pattern remains to be determined.Keywords
This publication has 27 references indexed in Scilit:
- The onset location of multiple sclerosis predicts the location of subsequent relapsesJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Predictors of the location of multiple sclerosis relapseJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- Multiple SclerosisAmerican Journal of Physical Medicine & Rehabilitation, 2003
- Randomized, comparative study of interferon β-1a treatment regimens in MSNeurology, 2002
- European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosisAnnals of Neurology, 2001
- Axonal Transection in the Lesions of Multiple SclerosisThe New England Journal of Medicine, 1998
- Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-upBrain, 1993
- A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic NeuritisThe New England Journal of Medicine, 1992
- Studies on the natural history of multiple sclerosis—8: Early prognostic features of the later course of the illnessJournal of Chronic Diseases, 1977